Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2217835120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Kevin A Murray und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Chemistry and Biochemistry and Biological Chemistry, UCLA-DOE Institute, Molecular Biology Institute, UCLA, Los Angeles, CA 90095. Hauptthemen laut MEDLINE: Synucleinopathies, Parkinson Disease, Multiple System Atrophy. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIA NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
The amyloid aggregation of alpha-synuclein within the brain is associated with the pathogenesis of Parkinson’s disease (PD) and other related synucleinopathies, including multiple system atrophy (MSA). Alpha-synuclein aggregates are a major therapeutic target for treatment of these diseases. We identify two small molecules capable of disassembling preformed alpha-synuclein fibrils. The compounds, termed CNS-11 and CNS-11g, disaggregate recombinant alpha-synuclein fibrils in vitro, prevent the intracellular seeded aggregation of alpha-synuclein fibrils, and mitigate alpha-synuclein fibril cytotoxicity in neuronal cells. Furthermore, we demonstrate that both compounds disassemble fibrils extracted from MSA patient brains and prevent their intracellular seeding. They also reduce in vivo alpha-synuclein aggregates in C. elegans . Both compounds also penetrate brain tissue in mice. A molecular dynamics–based computational model suggests the compounds may exert their disaggregating effects on the N terminus of the fibril core. These compounds appear to be promising therapeutic leads for targeting alpha-synuclein for the treatment of synucleinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Chemistry and Biochemistry and Biological Chemistry, UCLA-DOE Institute, Molecular Biology Institute, UCLA, Los Angeles, CA 90095.
- HHMI, UCLA, Los Angeles, CA 90095.
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095.
- Pasarow Mass Spectrometry Laboratory, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095.
- Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095.
- Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089.
ORCID-Profile: Kevin A Murray, David S Eisenberg
Förderung
- NIGMS NIH HHS
- NIA NIH HHS
- Howard Hughes Medical Institute
- HHS | National Institutes of Health
- DOE | SC | Biological and Environmental Research
Zitieren
APA
Murray, K. A., Hu, C. J., Pan, H., Lu, J., Abskharon, R., Bowler, J. T., Rosenberg, G. M., Williams, C. K., Elezi, G., Balbirnie, M., Faull, K. F., Vinters, H. V., Seidler, P. M., & Eisenberg, D. S. (2023). Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2217835120
Vancouver
Murray KA, Hu CJ, Pan H, Lu J, Abskharon R, Bowler JT, et al. Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2217835120
BibTeX
@article{Murray2023,
author = {Murray, Kevin A and Hu, Carolyn J and Pan, Hope and Lu, Jiahui and Abskharon, Romany and Bowler, Jeannette T and Rosenberg, Gregory M and Williams, Christopher K and Elezi, Gazmend and Balbirnie, Melinda and Faull, Kym F and Vinters, Harry V and Seidler, Paul M and Eisenberg, David S},
title = {Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2217835120}
}
EUVIMED